These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12241125)

  • 21. [Volume replacement solutions--pharmacology and clinical use].
    Adams HA; Piepenbrock S; Hempelmann G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jan; 33(1):2-17. PubMed ID: 9530478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the literature inconclusive about the harm of HES? We are not sure.
    Schetz M; Shaw AD; Vincent JL
    Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
    [No Abstract]   [Full Text] [Related]  

  • 23. Infusion of hydroxyethyl starch-containing fluids.
    Aubron C; Bellomo R
    Minerva Anestesiol; 2013 Sep; 79(9):1088-92. PubMed ID: 24042155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients.
    Boldt J; Brosch Ch; Röhm K; Papsdorf M; Mengistu A
    Br J Anaesth; 2008 Apr; 100(4):457-64. PubMed ID: 18305082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.
    He B; Xu B; Xu X; Li L; Ren R; Chen Z; Xiao J; Wang Y; Xu B
    Crit Care; 2015 Mar; 19(1):92. PubMed ID: 25886952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 28. Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?
    Hartog CS; Brunkhorst FM; Engel C; Meier-Hellmann A; Ragaller M; Welte T; Kuhnt E; Reinhart K;
    Wien Klin Wochenschr; 2011 Mar; 123(5-6):145-55. PubMed ID: 21359642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is fluid resuscitation with high-volume hydroxyethyl starch safe for the kidney in trauma patients?
    Xue FS; Liu GP; Li RP; Sun C
    Injury; 2015 Aug; 46(8):1698-9. PubMed ID: 25823537
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
    Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
    J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To use or not to use hydroxyethyl starch in intraoperative care: are we ready to answer the 'Gretchen question'?
    Heßler M; Arnemann PH; Ertmer C
    Curr Opin Anaesthesiol; 2015 Jun; 28(3):370-7. PubMed ID: 25887196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation.
    von Roten I; Madjdpour C; Frascarolo P; Burmeister MA; Fisch A; Schramm S; Bombeli T; Spahn DR
    Br J Anaesth; 2006 Apr; 96(4):455-63. PubMed ID: 16464978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of acute renal failure due to hydroxyethyl starch.
    Zhao HJ; Chen HP; Meng ZY; Wang Q
    Clin Nephrol; 2009 Mar; 71(3):329-32. PubMed ID: 19281747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyethyl starch-induced pruritus: clinical characteristics and influence of dose, molecular weight and substitution.
    Ständer S; Richter L; Osada N; Metze D
    Acta Derm Venereol; 2014 May; 94(3):282-7. PubMed ID: 24037065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the literature inconclusive about the harm from HES? Yes.
    Ertmer C; Annane D; Van Der Linden P
    Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.
    Blasco V; Leone M; Antonini F; Geissler A; Albanèse J; Martin C
    Br J Anaesth; 2008 Apr; 100(4):504-8. PubMed ID: 18256055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of 6% Hydroxyethyl Starch 130/0.4 Versus Crystalloid Solution on Structural Renal Damage Markers After Coronary Artery Bypass Grafting: A Post Hoc Subgroup Analysis of a Prospective Trial.
    Datzmann T; Hoenicka M; Reinelt H; Liebold A; Gorki H
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):205-211. PubMed ID: 29221978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.
    De Labarthe A; Jacobs F; Blot F; Glotz D
    Am J Med; 2001 Oct; 111(5):417-8. PubMed ID: 11599525
    [No Abstract]   [Full Text] [Related]  

  • 39. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed.
    Hartog CS; Kohl M; Reinhart K
    Anesth Analg; 2011 Mar; 112(3):635-45. PubMed ID: 21304149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids?
    Raja SG; Akhtar S; Shahbaz Y; Masood A
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1022-7. PubMed ID: 21398650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.